ReechPharma, LLC alternatives
Companies similar to ReechPharma, LLC on cro.directory, ranked by shared capabilities and locations focusing on Small Molecule, GLP Toxicology, In Vitro ADME / DMPK, and Phase IV / Post-Marketing. Below are the top 10 cros with overlapping structured profile data.
Shares Phase IV / Post-Marketing, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
Shares Phase IV / Post-Marketing, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
Shares Phase IV / Post-Marketing, In Vivo PK / PD Studies, Preclinical In Vitro Studies, and Phase III Clinical Trials.
Shares Phase IV / Post-Marketing, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
Shares GLP Toxicology, In Vitro ADME / DMPK, Phase IV / Post-Marketing, and In Vivo PK / PD Studies.
Shares Phase IV / Post-Marketing, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
Shares Phase I Clinical Trials, Translational Research, ICH Stability Studies, and Analytical Method Development & Validation.
Shares GLP Toxicology, In Vitro ADME / DMPK, Phase IV / Post-Marketing, and In Vivo PK / PD Studies.
Shares Phase IV / Post-Marketing, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
Shares Phase IV / Post-Marketing, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
How we pick similar companies: alternatives similarity uses shared services, modalities, locations, and site-specific capability fields — not sponsorship. Missing fields stay blank. Data comes from structured directory profiles.
← Back to ReechPharma, LLC profile
Interactive comparison
Lock shared capabilities to filter peers. Locked views are not indexed — the canonical page stays unlocked.
Capability locks
- Evanjo CRO
Shares Phase IV / Post-Marketing, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
- Voiant
Shares Phase IV / Post-Marketing, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
- Allucent
Shares Phase IV / Post-Marketing, In Vivo PK / PD Studies, Preclinical In Vitro Studies, and Phase III Clinical Trials.
- ObvioHealth
Shares Phase IV / Post-Marketing, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
- Altasciences
Shares GLP Toxicology, In Vitro ADME / DMPK, Phase IV / Post-Marketing, and In Vivo PK / PD Studies.
- PCM Trials
Shares Phase IV / Post-Marketing, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
- Eurofins Central Laboratory
Shares Phase I Clinical Trials, Translational Research, ICH Stability Studies, and Analytical Method Development & Validation.
- QPS
Shares GLP Toxicology, In Vitro ADME / DMPK, Phase IV / Post-Marketing, and In Vivo PK / PD Studies.
- Ergomed Clinical Research
Shares Phase IV / Post-Marketing, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
- TruTechnologies
Shares Phase IV / Post-Marketing, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
Markdown mirror: /alternatives/reechpharma.md